company background image
002349 logo

Jinghua Pharmaceutical Group XSEC:002349 Stock Report

Last Price

CN¥7.73

Market Cap

CN¥6.3b

7D

0.4%

1Y

-20.6%

Updated

23 Nov, 2024

Data

Company Financials

Jinghua Pharmaceutical Group Co., Ltd.

XSEC:002349 Stock Report

Market Cap: CN¥6.3b

002349 Stock Overview

Engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. More details

002349 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Jinghua Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jinghua Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥7.73
52 Week HighCN¥10.04
52 Week LowCN¥5.88
Beta0.13
11 Month Change-2.40%
3 Month Change18.02%
1 Year Change-20.64%
33 Year Change32.36%
5 Year Change79.35%
Change since IPO-27.35%

Recent News & Updates

Recent updates

Shareholder Returns

002349CN PharmaceuticalsCN Market
7D0.4%-1.5%-2.1%
1Y-20.6%-9.4%2.8%

Return vs Industry: 002349 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 002349 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 002349's price volatile compared to industry and market?
002349 volatility
002349 Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 002349 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002349's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19571,493Yunzhong Zhouwww.jinghuapharm.com

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd.

Jinghua Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Jinghua Pharmaceutical Group's earnings and revenue compare to its market cap?
002349 fundamental statistics
Market capCN¥6.29b
Earnings (TTM)CN¥216.58m
Revenue (TTM)CN¥1.44b

29.1x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002349 income statement (TTM)
RevenueCN¥1.44b
Cost of RevenueCN¥729.94m
Gross ProfitCN¥707.33m
Other ExpensesCN¥490.74m
EarningsCN¥216.58m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.27
Gross Margin49.21%
Net Profit Margin15.07%
Debt/Equity Ratio0.5%

How did 002349 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

35%

Payout Ratio